Is AIRDF or MRK a better dividend investment in 2026?

AIRDF currently yields 436.78% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: AIRDF offers higher current income.

What is the dividend yield difference between AIRDF and MRK?

AIRDF has a forward dividend yield of 436.78% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 434.02 percentage points.

Home › Compare › AIRDF vs MRK

AIRDF vs MRK: Dividend Comparison 2026

AIRDF yields 436.78% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AIRDF wins by $21939.93M in total portfolio value

INVESTMENT

TIME HORIZON10 years

AIRDF

● Live price

436.78%

Share price

$0.46

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21939.99M

Annual income

$15,127,069,046.22

Full AIRDF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — AIRDF vs MRK

📍 AIRDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AIRDF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AIRDF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AIRDF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AIRDF

Annual income on $10K today (after 15% tax)

$37,126.01/yr

After 10yr DRIP, annual income (after tax)

$12,858,008,689.29/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, AIRDF beats the other by $12,858,000,360.88/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AIRDF + MRK for your $10,000?

AIRDF: 50%MRK: 50%

100% MRK50/50100% AIRDF

Portfolio after 10yr

$10970.02M

Annual income

$7,563,539,422.18/yr

Blended yield

68.95%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AIRDF

No analyst data

Altman Z

-2.3

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AIRDF buys

MRK buys

No recent congressional trades found for AIRDF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAIRDFMRK

Forward yield	436.78% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$21939.99M ✓	$56.8K
Annual income after 10y	$15,127,069,046.22 ✓	$9,798.13
Total dividends collected	$21327.62M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: AIRDF vs MRK ($10,000, DRIP)

Year	AIRDF Portfolio	AIRDF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$54,378	$43,677.66	$11,206	$366.19	+$43.2K → AIRDF
2	$280,155	$221,970.92	$12,650	$502.35	+$267.5K → AIRDF
3	$1,368,550	$1,068,784.62	$14,407	$694.19	+$1.35M → AIRDF
4	$6,343,776	$4,879,427.20	$16,585	$967.82	+$6.33M → AIRDF
5	$27,926,240	$21,138,399.24	$19,342	$1,363.89	+$27.91M → AIRDF
6	$116,847,764	$86,966,687.13	$22,913	$1,947.19	+$116.82M → AIRDF
7	$465,103,974	$340,076,867.08	$27,662	$2,823.89	+$465.08M → AIRDF
8	$1,762,755,727	$1,265,094,474.41	$34,159	$4,173.35	+$1762.72M → AIRDF
9	$6,367,213,848	$4,481,065,220.18	$43,337	$6,308.80	+$6367.17M → AIRDF
10	$21,939,987,863	$15,127,069,046.22	$56,776	$9,798.13	+$21939.93M → AIRDF

AIRDF vs MRK: Complete Analysis 2026

AIRDF — Stock

Rocket Doctor AI Inc. provides personalized health care information services in Canada. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Rocket Doctor AI Inc. was formerly known as Treatment.com AI Inc. and changed its name to Rocket Doctor AI Inc. in August 2025. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

Full AIRDF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this AIRDF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AIRDF vs SCHD AIRDF vs JEPI AIRDF vs O AIRDF vs KO AIRDF vs MAIN AIRDF vs JNJ AIRDF vs ABBV AIRDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.